Related Experiment Videos
Assessment and reporting of clinical pharmacology information in drug labeling
D A Spyker1, E D Harvey, B E Harvey
1Purdue Pharma LP, Norwalk, Conn 06850-3690, USA. daniel.spyker@pharma.com
Clinical Pharmacology and Therapeutics
|March 31, 2000
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
From plants to animals: Pythium, Lagenidium, Aphanomyces, and other oomycete pathogens of animals seen through a one-health lens.
Australian veterinary journal·2026
Common arterial trunk in a cat: a high-resolution morphological analysis with micro-computed tomography.
Journal of veterinary cardiology : the official journal of the European Society of Veterinary Cardiology·2021
4-Methylpyrazole protects against acetaminophen hepatotoxicity in mice and in primary human hepatocytes.
Human & experimental toxicology·2018
Measuring Biomarker Progress.
Clinical pharmacology and therapeutics·2015
Mitochondrial pharmacology: its future is now.
Clinical pharmacology and therapeutics·2014
A single-arm clinical trial of a 48-hour intravenous N-acetylcysteine protocol for treatment of acetaminophen poisoning.
Clinical toxicology (Philadelphia, Pa.)·2014
Urogenital Infection Risk Associated With SGLT2 Inhibitors Versus DPP-4 Inhibitors in Type 2 Diabetes and Chronic Kidney Disease: A Nationwide Target Trial Emulation.
Clinical pharmacology and therapeutics·2026
In Silico Clinical Trials in Drug Development: Virtual Patients, Applications, and Regulatory Convergence.
Clinical pharmacology and therapeutics·2026
Empirical PK/PD Model for Differentiating Intrinsic Dosing Rules by Therapeutic Indication With Relevance for HIV-1 Latency Reversal.
Clinical pharmacology and therapeutics·2026
Model-Informed Dose Optimization of Anakinra in Preterm Neonates Implications for Safe and Effective Dosing.
Clinical pharmacology and therapeutics·2026
Untargeted Metabolomics Reveal New Endogenous Plasma Biomarkers Associated with CYP3A Inhibition in Humans.
Clinical pharmacology and therapeutics·2026
A Practical Guide to Implementing Real-World Evidence as Primary Basis for Approval and Label Expansion.
Clinical pharmacology and therapeutics·2026
Should we be monitoring patients on systemic dermatologic therapies for psychiatric adverse effects?: a proposed clinical framework.
The Journal of dermatological treatment·2026
Reconceptualizing Substance Use Disorders and Comorbidity: Moving Beyond Dual Diagnosis.
The Journal of nervous and mental disease·2026
Steered molecular dynamics and free-energy analysis of withanolide unbinding from tau kinases TTBK1 and GSK-3β.
Journal of biomolecular structure & dynamics·2026
Pain and Opioid Dose Reduction Based on Substance Use Disorder Status: Secondary Analysis from a Pragmatic Effectiveness Trial.
Journal of general internal medicine·2026